SIS
TEVA icon

Sound Income Strategies’s Teva Pharmaceuticals TEVA Stock Holding History

Sound Income Strategies’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,517
Closed -$45.9K – 2200
2026
Q1 		$45.9K Hold
1,517
– – ﹤0.01% 853
2025
Q4 		$48.2K Buy
1,517
+117
+8% +$2.88K ﹤0.01% 804
2025
Q3 		$28.1K Sell
1,400
-1,500
-52% -$26.3K ﹤0.01% 726
2025
Q2 		$48.6K Buy
2,900
+2,824
+3,716% +$45.6K ﹤0.01% 523
2025
Q1 		$1.17K Hold
76
– – ﹤0.01% 1323
2024
Q4 		$1.68K Hold
76
– – ﹤0.01% 1192
2024
Q3 		$1.37K Hold
76
– – ﹤0.01% 1198
2024
Q2 		$1.24K Hold
76
– – ﹤0.01% 1176
2024
Q1 		$1.07K Hold
76
– – ﹤0.01% 1167
2023
Q4 		$793 Hold
76
– – ﹤0.01% 1188
2023
Q3 		$775 Hold
76
– – ﹤0.01% 1026
2023
Q2 		$572 Hold
76
– – ﹤0.01% 1026
2023
Q1 		$673 Hold
76
– – ﹤0.01% 962
2022
Q4 		$693 Buy
+76
New +$663 ﹤0.01% 886

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Sound Income Strategies's TEVA Position: Q2 2026 in Review

Sound Income Strategies sold out of Teva Pharmaceuticals (TEVA) in Q2 2026, closing a stake of 1,517 shares — an estimated $45.9K sold.

Sound Income Strategies first reported a position in TEVA in Q4 2022 and held it in 14 quarters. The position peaked at $48.6K in Q2 2025. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Sound Income Strategies reported no remaining Teva Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Sound Income Strategies sold 1,517 Teva Pharmaceuticals shares in Q2 2026, an estimated $45.9K.
  • Sound Income Strategies first reported a position in Teva Pharmaceuticals in Q4 2022 and held it in 14 quarters.
  • Sound Income Strategies's Teva Pharmaceuticals position peaked at $48.6K in Q2 2025.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Sound Income Strategies's 13F filing for Q2 2026, filed 20 Jul 2026.